APCN, a world leader in deep brain stimulation, joins QBI

APCN, a world leader in deep brain stimulation, joins QBI

QBI has joined forces with the Asia-Pacific Centre for Neuromodulation (APCN) to boost the translation of research findings into the clinic.

APCN was founded in 2012, as a joint initiative of The University of Queensland and St Andrew’s War Memorial Hospital, to develop better and more cost-effective therapies for a range of neurological disorders.

In January this year APCN officially joined QBI, in a sign of their joint commitment to the integration of research, education and clinical care for the greatest human benefit.

QBI Director Pankaj Sah said APCN was an Asia–Pacific research leader in neuromodulation treatment.

“APCN builds on two decades of ground-breaking clinical research into the use of deep brain stimulation to treat Parkinson’s, among other conditions,” Professor Sah said.

“APCN brings together researchers from very different backgrounds to work together towards a single goal: to improve quality of life.

“The lead clinicians, Professor Peter Silburn and Associate Professor Terry Coyne, are central to APCN’s success, having performed more than 800 deep brain stimulation (DBS) procedures.

“They’re committed to following through research from building-block scientific discovery to new treatments.

“We welcome them and their team of 12 scientists and students to QBI, and look forward to working alongside them,” he said.

Current APCN research programs include:

  • Remote monitoring of people with Parkinson’s disease using GPS to measure quality of life, and personalisation of treatments.

  • Inserting first in-human ‘sense and respond” DBS devices in patients with treatment-resistant obses­sive compulsive disorder (OCD). This trial is one of the first of its kind in the world.

  • Testing next-generation stimulation and record devices to improve the design and functionality of new DBS devices.

Professor Sah also noted APCN’s commitment to educating the community and the next generation of scientists and clinicians.

“Most of the DBS clinicians in Australia were trained by Peter and Terry.

“We encourage APCN to play a role in our vibrant seminar series, sharing their work with scientists and the public,” he said.